Product Code: ETC12368526 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India hemostat market import shipment demonstrated strong growth with a CAGR of 15.4% from 2020 to 2024. However, there was a slight slowdown in growth between 2023 and 2024, with a negative growth rate of -2.8%. Overall, the market expanded significantly during the period, albeit showing signs of stabilization towards the end.
The India hemostat market is experiencing significant growth due to factors such as the increasing number of surgeries, rising prevalence of chronic diseases, and advancements in healthcare infrastructure. Hemostats, which are used to control bleeding during surgical procedures, are in high demand across various medical specialties. The market is characterized by a diverse range of products, including mechanical, active, and flowable hemostats. The adoption of minimally invasive surgical techniques is also driving the market growth, as these procedures often require effective hemostatic agents. Additionally, the focus on improving patient outcomes and reducing healthcare costs is leading to the development of innovative hemostatic products in the Indian market. Overall, the India hemostat market is poised for continued expansion in the coming years.
The current trends in the India hemostat market include the increasing adoption of advanced hemostatic agents and devices for better patient outcomes and reduced healthcare costs. There is a growing demand for minimally invasive surgical procedures, driving the development of hemostats that are effective in controlling bleeding quickly and efficiently. Additionally, the rise in surgical procedures across various medical specialties, such as cardiac and orthopedic surgeries, is fueling the demand for hemostats in the Indian market. Manufacturers are focusing on product innovations, such as hemostatic patches and powders, to cater to the evolving needs of healthcare providers and patients. The market is also witnessing strategic collaborations and partnerships between companies to expand their product portfolios and strengthen their market presence in India.
In the India hemostat market, some key challenges include increasing competition among market players leading to pricing pressures, limited awareness and adoption of advanced hemostatic products among healthcare professionals and patients, regulatory hurdles for product approval and market entry, and the presence of counterfeit or low-quality products in the market. Additionally, the fragmented healthcare system in India, with a mix of public and private providers, can make it challenging for hemostat manufacturers to effectively reach and educate their target audience. Addressing these challenges will require strategic marketing efforts, partnerships with healthcare facilities, and a focus on developing innovative, cost-effective solutions tailored to the needs of the Indian market.
Investment opportunities in the India hemostat market are promising due to factors such as the increasing number of surgeries, rising prevalence of chronic diseases, and growing awareness about advanced healthcare products. Key areas for investment include innovative hemostatic products, such as advanced hemostats with improved efficacy and safety profiles, as well as the development of hemostat delivery systems for better surgical outcomes. Additionally, investing in distribution networks and strategic partnerships with hospitals and healthcare providers can help companies penetrate the Indian market effectively. With the healthcare sector in India experiencing rapid growth and the demand for hemostats expected to rise, investing in this market presents opportunities for long-term growth and profitability.
The Indian government has implemented various policies related to the hemostat market to ensure the availability of safe and effective products. The Central Drugs Standard Control Organization (CDSCO) regulates the approval and monitoring of hemostatic products in India, ensuring compliance with quality and safety standards. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of medical devices, including hemostats, to ensure affordability and accessibility. Additionally, the government has introduced initiatives to promote domestic manufacturing of medical devices, including hemostats, through schemes such as Make in India and Atmanirbhar Bharat Abhiyan. These policies aim to foster innovation, improve access to high-quality healthcare products, and boost the growth of the hemostat market in India.
The India hemostat market is expected to witness significant growth in the coming years due to the increasing prevalence of chronic diseases, rising number of surgeries, and growing awareness about advanced hemostatic products. Factors such as the expanding healthcare infrastructure, technological advancements in hemostat products, and the emphasis on reducing healthcare costs will drive market growth. The increasing adoption of minimally invasive surgical procedures and the rising geriatric population will also contribute to the market expansion. However, challenges such as the high cost of advanced hemostat products and the presence of alternative hemostatic methods may hinder the market growth to some extent. Overall, the India hemostat market is poised for expansion, with opportunities for innovation and market penetration in the healthcare sector.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Hemostat Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Hemostat Market Revenues & Volume, 2021 & 2031F |
3.3 India Hemostat Market - Industry Life Cycle |
3.4 India Hemostat Market - Porter's Five Forces |
3.5 India Hemostat Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Hemostat Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.7 India Hemostat Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 India Hemostat Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 India Hemostat Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgeries in India |
4.2.2 Rising prevalence of chronic diseases requiring hemostats |
4.2.3 Technological advancements leading to the development of innovative hemostatic products |
4.3 Market Restraints |
4.3.1 High cost associated with hemostat products |
4.3.2 Lack of awareness among healthcare professionals about the benefits of hemostats |
4.3.3 Stringent regulatory requirements for approval of hemostatic products |
5 India Hemostat Market Trends |
6 India Hemostat Market, By Types |
6.1 India Hemostat Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Hemostat Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 India Hemostat Market Revenues & Volume, By Thrombin Based Hemostats, 2021 - 2031F |
6.1.4 India Hemostat Market Revenues & Volume, By Oxidized Regenerated Cellulose Based Hemostats, 2021 - 2031F |
6.1.5 India Hemostat Market Revenues & Volume, By Combination Hemostats, 2021 - 2031F |
6.1.6 India Hemostat Market Revenues & Volume, By Gelatin Based Hemostats, 2021 - 2031F |
6.1.7 India Hemostat Market Revenues & Volume, By Collagen Based Hemostats, 2021 - 2031F |
6.1.8 India Hemostat Market Revenues & Volume, By Others, 2021 - 2029F |
6.2 India Hemostat Market, By Formulation |
6.2.1 Overview and Analysis |
6.2.2 India Hemostat Market Revenues & Volume, By Matrix and Gel Hemostats, 2021 - 2031F |
6.2.3 India Hemostat Market Revenues & Volume, By Sheet and Pad Hemostats, 2021 - 2031F |
6.2.4 India Hemostat Market Revenues & Volume, By Sponge Hemostats, 2021 - 2031F |
6.2.5 India Hemostat Market Revenues & Volume, By Powder Hemostats, 2021 - 2031F |
6.2.6 India Hemostat Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 India Hemostat Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India Hemostat Market Revenues & Volume, By Orthopedic Surgery, 2021 - 2031F |
6.3.3 India Hemostat Market Revenues & Volume, By General Surgery, 2021 - 2031F |
6.3.4 India Hemostat Market Revenues & Volume, By Neurological Surgery, 2021 - 2031F |
6.3.5 India Hemostat Market Revenues & Volume, By Cardiovascular Surgery, 2021 - 2031F |
6.3.6 India Hemostat Market Revenues & Volume, By Reconstructive Surgery, 2021 - 2031F |
6.3.7 India Hemostat Market Revenues & Volume, By Gynecological Surgery, 2021 - 2029F |
6.4 India Hemostat Market, By Product |
6.4.1 Overview and Analysis |
6.4.2 India Hemostat Market Revenues & Volume, By Active Hemostats, 2021 - 2031F |
6.4.3 India Hemostat Market Revenues & Volume, By Passive Hemostats, 2021 - 2031F |
6.4.4 India Hemostat Market Revenues & Volume, By Combination Hemostats, 2021 - 2031F |
6.4.5 India Hemostat Market Revenues & Volume, By Others, 2021 - 2031F |
7 India Hemostat Market Import-Export Trade Statistics |
7.1 India Hemostat Market Export to Major Countries |
7.2 India Hemostat Market Imports from Major Countries |
8 India Hemostat Market Key Performance Indicators |
8.1 Adoption rate of advanced hemostatic products in Indian hospitals |
8.2 Number of surgical procedures performed in India annually |
8.3 Investment in research and development for hemostat technologies |
9 India Hemostat Market - Opportunity Assessment |
9.1 India Hemostat Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Hemostat Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.3 India Hemostat Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 India Hemostat Market Opportunity Assessment, By Product, 2021 & 2031F |
10 India Hemostat Market - Competitive Landscape |
10.1 India Hemostat Market Revenue Share, By Companies, 2024 |
10.2 India Hemostat Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |